pentobarbital will minimize the extent or outcome of etravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will reduce the level or effect of theophylline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will reduce the level or result of quinine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.

pentobarbital will decrease the level or effect of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.

pentobarbital will reduce the extent or effect of etravirine by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

pentobarbital will minimize the level or influence of triamcinolone acetonide injectable suspension by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

fentanyl transdermal and pentobarbital both increase sedation. Stay away from or Use Alternate Drug. Limit use to clients for whom substitute treatment selections are inadequate

pentobarbital will reduce the level or impact of suvorexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Solid CYP3A4 inducers may perhaps minimize suvorexant efficacy; if amplified suvorexant dose demanded, do not exceed twenty mg/working day

pentobarbital will minimize the extent or result of stiripentol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. If struggling to stay clear of coadministration of stiripentol with powerful CYP3A4 inducers, increase stiripentol dose.

Contraindicated (1)pentobarbital will minimize the level or result of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 get more info metabolism.

pentobarbital will reduce the extent or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will minimize the level or impact of rabeprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.

pentobarbital will minimize the extent or impact of nilotinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

pentobarbital will lower the level or impact of ramelteon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.